FP-0011

N/A

Report date: 2024/12/02 11:06:08
NME

Base Information

Drug NameFP-0011
Drug Alias NameFP-0011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptors inhibitors
TargetsGlutamate receptors
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMigraine DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMigraine DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksDrugBank